Literature DB >> 28426255

Pregabalin for the treatment of neuropathic pain: a narrative review for primary care providers.

Yvonne D'Arcy1, Bill McCarberg2, Bruce Parsons3, Regina Behar3, Andrew Thorpe3, Andrea Alexander4.   

Abstract

BACKGROUND: Neuropathic pain (NeP) is a distinct type of pain caused by damage to the nervous system itself. This often severe and chronic type of pain requires specific treatments that target the underlying pain pathophysiology. AIM: The purpose of the current narrative review is to provide an overview of pregabalin (Lyrica 1 ) for the treatment of NeP including its effects on pain, pain-related sleep interference, and other health-related outcomes, timing of therapeutic effect, safety and tolerability, and dosing. The information provided here will help primary care providers develop more effective NeP treatment strategies.

Entities:  

Keywords:  Pregabalin; neuropathic pain; primary care; review

Mesh:

Substances:

Year:  2017        PMID: 28426255     DOI: 10.1080/03007995.2017.1322051

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  2 in total

Review 1.  Pregabalin in the Management of Painful Diabetic Neuropathy: A Narrative Review.

Authors:  Shazli Azmi; Kariem T ElHadd; Andrew Nelson; Adam Chapman; Frank L Bowling; Anughara Perumbalath; Jonathan Lim; Andrew Marshall; Rayaz A Malik; Uazman Alam
Journal:  Diabetes Ther       Date:  2018-12-18       Impact factor: 2.945

2.  Comparison of the use of opioids only and pregabalin add-on for the treatment of neuropathic pain in cervical myelopathy patients: a pilot trial.

Authors:  Jong-Myung Jung; Chun Kee Chung; Chi Heon Kim; Seung Heon Yang; Yunhee Choi
Journal:  Sci Rep       Date:  2020-05-15       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.